Smith & Nephew (Smith & Nephew) 5-Year EBITDA Growth Rate

: -5.80% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

Smith & Nephew's EBITDA per Share for the six months ended in Dec. 2023 was $0.88.

During the past 12 months, Smith & Nephew's average EBITDA Per Share Growth Rate was 5.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 5.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -5.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Smith & Nephew was 67.60% per year. The lowest was -38.30% per year. And the median was 5.50% per year.

Competitive Comparison

For the Medical Devices subindustry, Smith & Nephew's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew 5-Year EBITDA Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's 5-Year EBITDA Growth Rate falls into.

Smith & Nephew 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Smith & Nephew (NYSE:SNN) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Smith & Nephew 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Smith & Nephew (Smith & Nephew) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SNNUF:USA SNl:UK SN.:UK NPW1:Germany NPWA:Germany NPW1:Germany S1NN34:Brazil

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.